EU adopts Critical Medicines Act to boost drug output
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- European Union reached a provisional deal to strengthen the supply of essential medicines, including antibiotics, insulin, vaccines, and painkillers.
- Critical Medicines Act targets supply‑chain weaknesses for more than 200 medicines deemed critical to Europe’s health security, covering treatments for rare diseases.
- Neophytos Charalambides, Cyprus health minister, said the agreement reduces vulnerabilities, diversifies supply chains, and boosts Europe’s capacity to produce critical medicines and ingredients locally.
- European Union aims to prevent drug shortages similar to those experienced during the Covid‑19 pandemic.
Why it matters: European patients and health systems gain a more reliable supply of over 200 essential medicines, while foreign suppliers risk losing market share as the EU expands domestic production and reduces import reliance.
Ask SkimNews
